Overview
The cost and timelines to research and develop new drugs are consistently rising and this, on top of other challenges, like more stringent regulatory approvals, is pushing companies to re-examine their operational models and look for process automation technologies.
Robotic Process Automation (RPA) has tremendous potential when it comes to clinical trials, pharmacovigilance efforts, regulatory compliance and other back office operations, and allows companies to bring drugs to market on an accelerated timeline.
Watch this webinar to hear industry experts speak about the RPA use cases in life sciences and its positive impact on operational efficiency and costs. The event is jointly organized by Nividous and Kinapse, now a part of Syneos Health, the world’s only fully integrated biopharma solutions organization.